US Federal 2025-2026 Regular Session

US Federal House Bill HB5316

Introduced
9/11/25  

Caption

Drug Shortage Compounding Patient Access Act of 2025

Companion Bills

No companion bills found.

Previously Filed As

US SB0282

Compounding drugs; registration of medical spas.

US SB2665

Drug Shortage Prevention Act of 2025

US HB6117

Patient Device Data Access Act of 2025

US SB652

Protecting Patients from Deceptive Drug Ads Act

US H1407

Compounding Pharmacies

US HB6509

SAFE Drugs Act of 2025 Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2025

US SB3794

SAFE Drugs Act of 2026 Safeguarding Americans from Fraudulent and Experimental Drugs Act of 2026

US HB4441

Patient Access to Innovative New Technologies Act of 2025

US HF3832

Definition of compounding of a drug amended to exempt the use of a flavoring agent.

US SF3783

Compounding of a drug definition modification to exempt the use of a flavoring agent

Similar Bills

CA AB2442

Peptides.

HI HB2164

Relating To Workers' Compensation.

HI SB2751

Relating To Workers' Compensation.

CO SB066

Regulation of Compounded Weight-Loss Medication

CA AB1990

Pharmacy Law: compounded medications: consumer protection.

LA SB253

Provides relative to peptides. (8/1/26)

IN SB0282

Compounding drugs; registration of medical spas.

TX HB3785

Relating to labeling requirements for compounded drug products.